Menopausal hormone therapy has no evidence-based role for the primary or secondary prevention of coronary heart disease. Coronary prevention should involve lifestyle and pharmacologic interventions documented as beneficial in randomized clinical trials and promulgated in national guidelines.
aProfessor of Medicine (Cardiology),Emory University School of Medicine; Chief of Cardiology, Grady Memorial Hospital; Consultant, Emory Heart & Vascular Center, Atlanta, GA, USA
Nanette K. Wenger, M.D., Emory University School of Medicine, 69 Jesse Hill Jr. Drive, SE, Atlanta, GA 30303, USA
ABSTRACT
